Top compounds associated with response to CILP


Feature Type Standardized
Nominal ANOVA
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.054 0.08
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.061 0.09
mRNA Topotecan CTRPv2 pan-cancer AAC -0.056 0.09
mRNA lenalidomide FIMM pan-cancer AAC -0.29 0.09
mRNA CI-1040 GDSC1000 pan-cancer AAC -0.055 0.09
mRNA marinopyrrole A CTRPv2 pan-cancer AAC -0.075 0.09
mRNA DBeQ CTRPv2 pan-cancer AAC -0.064 0.09
mRNA apicidin CTRPv2 pan-cancer AAC -0.054 0.09
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.055 0.09
mRNA SMER-3 CTRPv2 pan-cancer AAC -0.066 0.09
Download CSV